The Ex-US Rotation Is the Biggest Trade 13F Filings Can Barely See

Two years into a genuine reversal of US equity leadership, there is an uncomfortable fact sitting underneath most institutional holdings analysis: the trade is largely invisible in the filings.

In 2025, the MSCI EAFE index returned roughly 32% and MSCI Emerging Markets climbed about 34%, against an S&P 500 gain of nearly 18%. That gap was not a fluke that mean-reverted. Through 2026 year to date, developed markets outside the US are up around 9.6% and emerging markets roughly 7%, broadly matching or beating the S&P's near-9%. Consensus has EM earnings growing about 29% this year versus roughly 14% in the US.

If a large fraction of professional capital has been rotating out of US concentration and into ex-US equities since early 2025, you would expect to see it in the 13F record. Mostly, you don't — and the reason is structural, not behavioral.

What Form 13F actually requires

Form 13F covers "section 13(f) securities": US exchange-traded equities, certain closed-end funds, ETFs, and convertible instruments that appear on the SEC's official list. A Tokyo-listed industrial, a Paris-listed luxury house, a Taiwan-listed foundry, an Indian bank listed only in Mumbai — none of them are reportable, no matter how large the position or how long it's been held.

So a manager can move a third of the book into non-US equities and file a 13F that shows a smaller, US-only portfolio with no indication of where the money went. Aggregate dollar value drops. The position count drops. Every screen built on filing data reads that as de-risking when it may be nothing of the sort.

This is the same mechanic that hides short positions, most debt, commodities and private holdings — but it bites harder here, because the missing exposure is the year's dominant asset-allocation decision rather than a niche instrument.

The three windows that remain

Ex-US exposure does show up in filings, just through narrow and distorting apertures.

ADRs. Depositary receipts on US exchanges are reportable, which is why a handful of large foreign names dominate any "international" cut of 13F data. The problem is selection: the ADR universe is a small, liquidity-biased slice of global markets, skewed toward mega-caps in a few sectors. A fund with heavy ADR exposure looks internationally diversified; a fund that bought the same countries via local lines looks like it owns nothing abroad at all.

ETF wrappers. US-listed international ETFs are reportable. When you see broad-market EM or EAFE funds appearing in institutional books, that's often the cleanest available signal of a top-down allocation shift — and worth reading as a macro statement rather than a stock pick. The aggregated positioning on the macro consensus page is built around exactly this cohort, because macro-driven managers tend to express country and currency views in instruments that happen to be reportable.

US-listed companies with foreign revenue. The least reliable window, but not worthless. Multinationals with heavy ex-US revenue transmit a weaker dollar and faster foreign nominal growth into reported earnings. It's indirect exposure, and it comes bundled with all the US-market beta the investor may have been trying to escape.

Why this distorts the numbers you're reading

Three specific errors follow from treating a 13F as a portfolio.

First, shrinking books get misread as caution. A fund whose reported AUM falls quarter over quarter may have sold nothing — it may have reallocated into securities that fall outside the form. Before concluding a manager turned defensive, it's worth checking whether their US names were trimmed proportionally or whether specific positions were exited outright. The per-manager detail on the investors pages makes that distinction legible in a way an aggregate value does not.

Second, US concentration looks worse than it is. Every "top 10 holdings are 70% of the portfolio" statistic is computed on the reportable portion only. For a globally invested manager, real concentration may be dramatically lower.

Third, consensus and overlap measures are biased toward US mega-caps. When you count how many institutions hold a given name, the denominator is the set of positions that happen to be reportable — which systematically overstates crowding in large US stocks and understates it everywhere else. Reading overlap data with that bias in mind is the difference between a finding and an artifact.

What's checkable right now

The latest visible book is Q2, filed August 14 against June 30 positions; Q3 filings land November 16. So the useful exercise this month is a comparative one: look at how each manager's reported dollar value moved across the last four quarters, then check whether the drop was broad-based trimming or concentrated exits, and whether any international ETF or ADR exposure appeared alongside it. The flow data shows the direction; the caveat is that its universe is US-listed by construction.

The rotation out of US-only positioning is real, measurable in index returns, and mostly outside the frame of the disclosure regime built to observe institutional behavior. That's worth remembering before treating a smaller 13F as a smaller conviction.

---

Data sourced from public SEC 13F filings. Educational research only — not investment advice.